Clinical Trials Arena July 9, 2025
Despite the threat of a 200% tariff, most pharma stocks remained stable.
US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global supply chains.
Speaking at the White House on 8 July, Trump said: “We’ll be announcing something very soon on pharmaceuticals. We’re going to give people about a year, year and a half to come in, and after that they’re going to be tariffed if they have to bring the pharmaceuticals into the country at a very high rate, like 200%.”
This is significantly higher than the 25% tariff threatened by the US President in March 2025. When 10% tariffs came into effect for several countries, pharmaceuticals were given a...
Today's Sponsors
Today's Sponsor